Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nihon Pharmaceutical Co., Ltd. (often referred to as Nippon Seiyaku) is a specialized Japanese pharmaceutical company and a subsidiary of Takeda Pharmaceutical Company. Established in 1921, the company is a leader in the Japanese market for plasma-derived medicinal products, including albumin, immunoglobulins, and blood coagulation factors. Beyond its core blood products business, Nihon Pharmaceutical provides a wide range of gastrointestinal treatments, such as enemas and lubricating jellies, as well as surgical aids like hemostatic agents. Headquartered in Tokyo, the company operates multiple manufacturing facilities in Japan, including sites in Narita and Ibaraki, ensuring a stable supply of essential life-saving therapies. As a key member of the Takeda Group, it plays a critical role in the domestic healthcare infrastructure by providing hospital-use medications and immunology solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nippon Seiyaku.